<--- Back to Details
First PageDocument Content
Aromatase inhibitor / Cancer / Adjuvant therapy / Mammography / Exemestane / Breast self-examination / Ovarian cancer / Oncotype DX / Risk factors for breast cancer / Medicine / Breast cancer / Tamoxifen
Date: 2013-02-01 00:30:09
Aromatase inhibitor
Cancer
Adjuvant therapy
Mammography
Exemestane
Breast self-examination
Ovarian cancer
Oncotype DX
Risk factors for breast cancer
Medicine
Breast cancer
Tamoxifen

Upper GI Structured Interviews Results

Add to Reading List

Source URL: www.wcmics.org

Download Document from Source Website

File Size: 193,80 KB

Share Document on Facebook

Similar Documents

Profiling of mass spectrometry data for ovarian cancer detection using negative correlation learning Shan He, Huanhuan Chen, Xiaoli Li, and Xin Yao The Centre of Excellence for Research in Computational Intelligence and

DocID: 1vn3H - View Document

Case  study  for  data  visualiza1on   using  NaviCell  Data  Visualiza1on   Web  Service   TCGA  Ovarian  cancer  samples   Map:  Mast  cell  network  

DocID: 1velf - View Document

For personal use only BARD1 ANNOUNCES POSITIVE RESULTS FROM OC-400 STUDY OF BARD1-OVARIAN TEST • Successful completion of OC-400 Study to evaluate the accuracy of BARD1-Ovarian for detection of ovarian cancer using th

DocID: 1ve2D - View Document

Commentary Long-term breast cancer risk following ovarian stimulation in young egg donors: a call for follow-up, research and informed consent Jennifer Schneider a,*, Jennifer Lahl b, Wendy Kramer c

DocID: 1v7BC - View Document

Clinical Guideline Annals of Internal Medicine Screening for Ovarian Cancer: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement

DocID: 1uqkO - View Document